Featured Stories

Caught in the Act

First snapshots of cancer protein B-Raf illuminate basic biology, and can impact drug design for pediatric low grade glioma brain tumor…

> Read More

Pediatric Brain Tumor Foundation and American Association for Cancer Research Announce RFP for Research Grant to Optimize Drug Dosing Strategies for PLGA Patients

The Pediatric Brain Tumor Foundation’s PLGA Fund and the American Association for Cancer Research (AARC) are excited to announce a request for…

> Read More

Study Results: New PLGA Research Demonstrates the Power of Teamwork in Improving Outcomes for Kids with Brain Tumors

Children diagnosed with low-grade astrocytomas, the most common type of pediatric brain tumor, have close to 90 percent overall survival rates.…

> Read More

Pediatric Brain Tumor Foundation and A Kids’ Brain Tumor Cure Join Forces to Change the Outcome for All Children with Brain Cancer

ASHEVILLE, N.C. and BOSTON -- The Pediatric Brain Tumor Foundation (PBTF) and A Kids’ Brain Tumor Cure (AKBTC, a/k/a PLGA Foundation) are merging…

> Read More

Attainment of Functional and Social Independence in Adult Survivors of Pediatric CNS Tumors: A Report from the St Jude Lifetime Cohort Study

Beyond survival, achieving independence is a primary goal for adult survivors of pediatric CNS tumors. Researchers at St. Jude recently concluded a…

> Read More

Clinical Trials and Expanded Access to Experimental Drugs/Devices Get a Boost from Recent Legislation

When you or a family member is diagnosed with a serious or life-threatening disease, you have choices to make about your treatment once standard…

> Read More